Comment on CMS-2026-1255-0001

Summary: The American Society of Pediatric Nephrology (ASPN) supports the proposed rule to modernize and streamline prior authorization processes for drugs to reduce administrative burdens and improve patient access. They advocate for standardized electronic prior authorization, specific reporting metrics for pediatric medications, and stricter enforcement of turnaround times to ensure timely care for children with kidney disease.